Literature DB >> 25578393

The 25-hydroxyvitamin D3 C-3 epimer: distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC).

Pamela L Lutsey1, John H Eckfeldt2, Ejovwoke R Ogagarue3, Aaron R Folsom4, Erin D Michos5, Myron Gross2.   

Abstract

BACKGROUND: Little is known about the vitamin D3 epimer [3-epi-25(OH)D3], particularly in adults. We describe characteristics of the D3 epimer within the community-based ARIC cohort.
METHODS: The vitamin D3 epimer, 25(OH)D3, and 25(OH)D2 were measured using LC-MS/MS in stored serum collected in 1990-1992 from 9,887 white and 3,221 black ARIC study participants, aged 46-70years. Cross-sectional characteristics were explored.
RESULTS: Concentrations of the epimer were quantifiable (≥1.41ng/ml) in 33.4% of whites and 15.0% of blacks and made up on average 3.23% and 2.25% of total D3 [epimer+25(OH)D3] concentrations, respectively. Epimer levels were positively correlated with 25(OH)D3 in both whites (r=0.54) and blacks (r=0.36) and were unrelated to 25(OH)D2 concentrations. Overall, epimer levels were associated with participant characteristics in a manner similar to that typically observed for 25(OH)D3. Including the epimer in the calculation of total 25(OH)D resulted in approximately 2% of participants being reclassified from being clinically 25(OH)D deficient to having suboptimal levels.
CONCLUSIONS: Low concentrations of the D3 epimer were present in adult serum and overall the epimer concentration is moderately correlated with the 25(OH)D3 concentration. The reclassification of participant's clinical 25(OH)D status upon inclusion of the epimer was minimal.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  25-Hydroxyvitamin D(3) C-3 epimer; Atherosclerosis Risk in Communities Study (ARIC); Race; Reclassification; Vitamin D

Mesh:

Substances:

Year:  2015        PMID: 25578393      PMCID: PMC4339618          DOI: 10.1016/j.cca.2014.12.036

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  28 in total

Review 1.  The measurement of vitamin D: analytical aspects.

Authors:  Joseph E Zerwekh
Journal:  Ann Clin Biochem       Date:  2004-07       Impact factor: 2.057

2.  NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary.

Authors:  Elizabeth A Yetley; Christine M Pfeiffer; Rosemary L Schleicher; Karen W Phinney; David A Lacher; Sylvia Christakos; John H Eckfeldt; James C Fleet; George Howard; Andrew N Hoofnagle; Siu L Hui; Gary L Lensmeyer; Joseph Massaro; Munro Peacock; Bernard Rosner; Donald Wiebe; Regan L Bailey; Paul M Coates; Anne C Looker; Christopher Sempos; Clifford L Johnson; Mary Frances Picciano
Journal:  J Nutr       Date:  2010-09-29       Impact factor: 4.798

3.  C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status.

Authors:  Ravinder J Singh; Robert L Taylor; G Satyanarayana Reddy; Stefan K G Grebe
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

6.  Metabolism of 1alpha,25-dihydroxyvitamin D(3) and its C-3 epimer 1alpha,25-dihydroxy-3-epi-vitamin D(3) in neonatal human keratinocytes.

Authors:  G S Reddy; K R Muralidharan; W H Okamura; K Y Tserng; J A McLane
Journal:  Steroids       Date:  2001 Mar-May       Impact factor: 2.668

7.  Serum levels of 3-epi-25-OH-D3 during hypervitaminosis D in clinical practice.

Authors:  F Granado-Lorencio; I Blanco-Navarro; B Pérez-Sacristán; E Donoso-Navarro; R Silvestre-Mardomingo
Journal:  J Clin Endocrinol Metab       Date:  2012-10-04       Impact factor: 5.958

8.  C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation.

Authors:  Maya Kamao; Syuichiro Tatematsu; Susumi Hatakeyama; Toshiyuki Sakaki; Natsumi Sawada; Kuniyo Inouye; Keiichi Ozono; Noboru Kubodera; G Satyanarayana Reddy; Toshio Okano
Journal:  J Biol Chem       Date:  2004-02-02       Impact factor: 5.157

Review 9.  The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis.

Authors:  Mark J Bolland; Andrew Grey; Greg D Gamble; Ian R Reid
Journal:  Lancet Diabetes Endocrinol       Date:  2014-01-24       Impact factor: 32.069

10.  Sequential-saturation-type assay for serum 25-hydroxyvitamin D.

Authors:  G Ellis; K Dixon
Journal:  Clin Chem       Date:  1977-05       Impact factor: 8.327

View more
  23 in total

1.  Markers of vitamin D metabolism and incidence of clinically diagnosed abdominal aortic aneurysm: The Atherosclerosis Risk in Communities Study.

Authors:  Pamela L Lutsey; Mary R Rooney; Aaron R Folsom; Erin D Michos; Alvaro Alonso; Weihong Tang
Journal:  Vasc Med       Date:  2018-02-05       Impact factor: 3.239

2.  National Estimates of Serum Total 25-Hydroxyvitamin D and Metabolite Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry in the US Population during 2007-2010.

Authors:  Rosemary L Schleicher; Maya R Sternberg; Anne C Looker; Elizabeth A Yetley; David A Lacher; Christopher T Sempos; Christine L Taylor; Ramon A Durazo-Arvizu; Khin L Maw; Madhulika Chaudhary-Webb; Clifford L Johnson; Christine M Pfeiffer
Journal:  J Nutr       Date:  2016-04-06       Impact factor: 4.798

3.  Biomarkers of Vitamin D Status and Risk of ESRD.

Authors:  Casey M Rebholz; Morgan E Grams; Pamela L Lutsey; Andrew N Hoofnagle; Jeffrey R Misialek; Lesley A Inker; Andrew S Levey; Elizabeth Selvin; Chi-Yuan Hsu; Paul L Kimmel; Ramachandran S Vasan; John H Eckfeldt; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2015-10-23       Impact factor: 8.860

4.  Serum Vitamin D Concentrations and Cognitive Change Over 20 Years: The Atherosclerosis Risk in Communities Neurocognitive Study.

Authors:  Andrea L C Schneider; Di Zhao; Pamela L Lutsey; Rebecca F Gottesman; A Richey Sharrett; Andreea M Rawlings; Alvaro Alonso; David Knopman; Thomas H Mosley; Elizabeth Selvin; Erin D Michos
Journal:  Neuroepidemiology       Date:  2018-08-09       Impact factor: 3.282

5.  Temporal increases in 25-hydroxyvitamin D in midlife women: Longitudinal results from the Study of Women's Health Across the Nation.

Authors:  Deborah M Mitchell; Kristin Ruppert; Nisha Udupa; Fatima Bassir; Karin Darakananda; Daniel H Solomon; Yinjuan Lian; Jane A Cauley; Arun S Karlamangla; Gail A Greendale; Joel S Finkelstein; Sherri-Ann M Burnett-Bowie
Journal:  Clin Endocrinol (Oxf)       Date:  2019-04-24       Impact factor: 3.478

6.  Serum 25-hydroxyvitamin D is associated with incident peripheral artery disease among white and black adults in the ARIC study cohort.

Authors:  Ian R Rapson; Erin D Michos; Alvaro Alonso; Alan T Hirsch; Kunihiro Matsushita; Jared P Reis; Pamela L Lutsey
Journal:  Atherosclerosis       Date:  2017-01-16       Impact factor: 5.162

7.  Short-term Variability of Vitamin D-Related Biomarkers.

Authors:  Pamela L Lutsey; Christina M Parrinello; Jeffrey R Misialek; Andy N Hoofnagle; Clark M Henderson; Thomas J Laha; Erin D Michos; John H Eckfeldt; Elizabeth Selvin
Journal:  Clin Chem       Date:  2016-09-30       Impact factor: 8.327

8.  Serum 25-hydroxyvitamin D concentrations in Mid-adulthood and Parkinson's disease risk.

Authors:  Srishti Shrestha; Pamela L Lutsey; Alvaro Alonso; Xuemei Huang; Thomas H Mosley; Honglei Chen
Journal:  Mov Disord       Date:  2016-04-19       Impact factor: 10.338

9.  Factors Associated With Change in 25-Hydroxyvitamin D Levels Over Longitudinal Follow-Up in the ARIC Study.

Authors:  Rebeccah A McKibben; Di Zhao; Pamela L Lutsey; Andrea L C Schneider; Eliseo Guallar; Thomas H Mosley; Erin D Michos
Journal:  J Clin Endocrinol Metab       Date:  2015-10-28       Impact factor: 5.958

10.  Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study.

Authors:  Junichi Ishigami; Bernard G Jaar; Casey M Rebholz; Morgan E Grams; Erin D Michos; Myles Wolf; Csaba P Kovesdy; Shinichi Uchida; Josef Coresh; Pamela L Lutsey; Kunihiro Matsushita
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.